The Latest Breaking News from Pfizer

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

The world is watching the Jan. 6 hearings in the United States in dismay and contemplating the possible end of the American democratic experiment.

21.2 million Americans received their second booster by the end of July.

After taking Paxlovid, Biden tested negative for several days, then positive. He's not the only one

The “living with COVID” strategy being pursued by many countries relies heavily on two key pillars. First, that vaccines continue to protect most people from severe disease. And second, that where they don’t, people will receive antiviral treatments. But are the antivirals currently available sufficiently effective, accessible and durable?

The Food and Drug Administration reportedly has a new strategy for rolling out new booster shots that should bring needed clarity to COVID vaccination in the U.S. Going forward, most Americans will get the same advice about when to get their next shots.

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound